Xeris Biopharma Holdings
XERS
XERS
96 hedge funds and large institutions have $126M invested in Xeris Biopharma Holdings in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.23% less ownership
Funds ownership: 54.59% → 52.37% (-2.2%)
16% less capital invested
Capital invested by funds: $150M → $126M (-$23.4M)
Holders
96
Holding in Top 10
–
Calls
$11.3M
Puts
$2.6M
Top Buyers
| 1 | +$923K | |
| 2 | +$775K | |
| 3 | +$715K | |
| 4 |
Goldman Sachs
New York
|
+$689K |
| 5 |
Two Sigma Investments
New York
|
+$625K |
Top Sellers
| 1 | -$1.4M | |
| 2 | -$1.21M | |
| 3 | -$1.04M | |
| 4 |
AGM
Alpine Global Management
New York
|
-$998K |
| 5 |
DAM
Deltec Asset Management
New York
|
-$784K |